Year in review 2013: Chronic obstructive pulmonary disease, asthma and airway biology

Respirology

Volumn 19, Issue 3, 2014, Pages 438-447

  Ko, Fanny W S ^a   Lim, Tow K ^b   Hancox, Robert J ^c   Yang, Ian A ^d  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

airway biology; asthma; chronic obstructive pulmonary disease; diagnosis; treatment

Indexed keywords

ADVERSE OUTCOME; AIRWAY; AIRWAY MONITORING SYSTEM; AIRWAY OBSTRUCTION; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; GASTRITIS; GASTROINTESTINAL DISEASE; GENOMICS; HEART FAILURE; HUMAN; LUNG CANCER; MUSCLE WEAKNESS; PATIENT MONITORING; PEPTIC ULCER; PHENOTYPE; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; PULMONARY REHABILITATION; RESPIRATORY TRACT DISEASE; REVIEW; RISK ASSESSMENT; WEIGHT REDUCTION; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY SYSTEM; RISK FACTOR;

ASTHMA; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY SYSTEM; RISK FACTORS;

EID: 84896316102     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12252     Document Type: Review

References (94)

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2013. [Accessed 18 Nov 2013.] Available from URL: http://www.goldcopd.org/uploads/users/files/GOLD-Report-2013-Feb20. pdf
2. Mannino DM, Davis KJ, DiSantostefano RL,. Chronic respiratory disease, comorbid cardiovascular disease, and mortality in a representative adult U.S. cohort. Respirology 2013; 18: 1083-1088.
3. Boschetto P, Fucili A, Stendardo M, Malagù M, Parrinello G, Casimirri E, Potena A, Ballerin L, Fabbri LM, Ferrari R, et al. Occurrence and impact of chronic obstructive pulmonary disease in elderly patients with stable heart failure. Respirology 2013; 18: 125-130.
4. Kamble NL, Khan NA, Kumar N, Nayak HK, Daga MK,. Study of gastro-oesophageal reflux disease in patients with mild-to-moderate chronic obstructive pulmonary disease in India. Respirology 2013; 18: 463-467.
5. Terada K, Muro S, Sato S, Ohara T, Haruna A, Marumo S, Kinose D, Ogawa E, Hoshino Y, Niimi A, et al. Impact of gastro-oesophageal reflux disease symptoms on COPD exacerbation. Thorax 2008; 63: 951-955.
6. Siva R, Birring SS, Berry M, Rowbottom A, Pavord ID,. Peptic ulceration, Helicobacter pylori seropositivity and chronic obstructive pulmonary disease. Respirology 2013; 18: 728-731.
7. Minatsuki C, Yamamichi N, Shimamoto T, Kakimoto H, Takahashi Y, Fujishiro M, Sakaguchi Y, Nakayama C, Konno-Shimizu M, Matsuda R, et al. Background factors of reflux esophagitis and non-erosive reflux disease: a cross-sectional study of 10 837 subjects in Japan. PLoS ONE 2013; 8: e69891.
8. Zhang J, Zhou J-B, Lin X-F, Wang QUN, Bai C-X, Hong Q-Y,. Prevalence of undiagnosed and undertreated chronic obstructive pulmonary disease in lung cancer population. Respirology 2013; 18: 297-302.
9. Cholendra A, Mohan SK, Premanand R, Chandrasekar A, Badhareenadhudu B, Kanala KR,. Oxidative stress and antioxidant enzyme activity in South Indian male smokers with chronic obstructive pulmonary disease. Respirology 2013; 18: 1069-1075.
10. Dancer R, Sansom DM,. Regulatory T cells and COPD. Thorax 2013; 68: 1176-1178.
11. Shen Y, Yang T, Wang T, Chen L, Wen F,. Elevated circulating cytotoxic T lymphocyte-associated antigen-4 levels are related to lung function and inflammation in chronic obstructive pulmonary disease. Respirology 2013; 18: 885-886.
12. Wang R-T, Li J-Y, Cao Z-G, Li Y,. The mean platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary disease. Respirology 2013; 18: 1244-1248.
13. Warwick G, Thomas PS, Yates DH,. Non-invasive biomarkers in exacerbations of obstructive lung disease. Respirology 2013; 18: 874-884.
14. Trauer JM, Gielen CA, Aminazad ALI, Steinfort CL,. Ambulatory oximetry fails to predict survival in chronic obstructive pulmonary disease with mild-to-moderate hypoxaemia. Respirology 2013; 18: 377-382.
15. Günay E, Kaymaz D, Selçuk NT, Ergün P, Sengül F, Demir N,. The effect of nutritional status in individuals with COPD undergoing pulmonary rehabilitation. Respirology 2013; 18: 1217-1222.
16. Zhou Y, Chen R,. Risk factors and intervention for chronic obstructive pulmonary disease in China. Respirology 2013; 18 (Suppl. 3): 4-9.
17. Tang Y, Jiang M, Li D-R, Guan W-J, Liang Y-H, Li S-Y, Zheng J-P, Chen R-C, Zhong N-S,. Association between awareness of harmful effects of smoking and smoking cessation advice provided by hospital chest physicians in Guangzhou, China: a multi-institutional cross-sectional survey. Respirology 2013; 18: 790-796.
18. Dean E, Bodner M, Al-Bannay H, Li Z,. Smoking cessation practice and research in China: what's history and culture got to do with it? Respirology 2013; 18: 741-743.
19. Fukuchi Y, Samoro R, Fassakhov R, Taniguchi H, Ekelund J, Carlsson L-G, Ichinose M,. Budesonide/formoterol via Turbuhaler® versus formoterol via Turbuhaler® in patients with moderate to severe chronic obstructive pulmonary disease: phase III multinational study results. Respirology 2013; 18: 866-873.
20. Nannini LJ, Poole P, Milan SJ, Kesterton A,. Combined corticosteroid and long-acting beta2-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2013; (8): CD006826.
21. Janson C, Larsson K, Lisspers KH, Stallberg B, Stratelis G, Goike H, Jörgensen L, Johansson G,. Pneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting beta2 agonist: observational matched cohort study (PATHOS). BMJ 2013; 346: f3306.
22. Gershon A, Croxford R, Calzavara A, To T, Stanbrook MB, Upshur R, Stukel TA,. Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease. JAMA Intern. Med. 2013; 173: 1175-1185.
23. Wilchesky M, Ernst P, Brophy JM, Platt RW, Suissa S,. Bronchodilator use and the risk of arrhythmia in COPD: part 2: reassessment in the larger Quebec cohort. Chest 2012; 142: 305-311.
24. de Jong E, van Dijk WD, Heijdra Y, Lenders JWM, van Weel C, Akkermans R, Schermer TRJ,. Short-acting anticholinergic bronchodilation does not increase cardiovascular events in smokers with mild to moderate pulmonary obstruction. Respirology 2013; 18: 663-668.
25. Duckers JM, Evans BA, Fraser WD, Stone MD, Bolton CE, Shale DJ,. Low bone mineral density in men with chronic obstructive pulmonary disease. Respir. Res. 2011; 12: 101.
26. Halpern MT, Schmier JK, Van Kerkhove MD, Watkins M, Kalberg CJ,. Impact of long-term inhaled corticosteroid therapy on bone mineral density: results of a meta-analysis. Ann. Allergy Asthma Immunol. 2004; 92: 201-207; quiz 7-8, 67.
27. Mathioudakis AG, Amanetopoulou SG, Gialmanidis IP, Chatzimavridou- Grigoriadou V, Siasos G, Evangelopoulou E, Mathioudakis GA,. Impact of long-term treatment with low-dose inhaled corticosteroids on the bone mineral density of chronic obstructive pulmonary disease patients: aggravating or beneficial? Respirology 2013; 18: 147-153.
28. Lun C-T, Chan VL, Leung W-S, Cheung APS, Cheng S-L, Tsui MSN, Chu C-M,. A pilot randomized study comparing two methods of non-invasive ventilation withdrawal after acute respiratory failure in chronic obstructive pulmonary disease. Respirology 2013; 18: 814-819.
29. Hannan LM, Tan S, Hopkinson KIM, Marchingo E, Rautela L, Detering K, Berlowitz DJ, McDonald CF, Howard ME,. Inpatient and long-term outcomes of individuals admitted for weaning from mechanical ventilation at a specialized ventilation weaning unit. Respirology 2013; 18: 154-160.
30. Hess DR,. The role of noninvasive ventilation in the ventilator discontinuation process. Respir. Care 2012; 57: 1619-1625.
31. Pandharipande P, Banerjee A, McGrane S, Ely EW,. Liberation and animation for ventilated ICU patients: the ABCDE bundle for the back-end of critical care. Crit. Care 2010; 14: 157.
32. Revitt O, Sewell L, Morgan MDL, Steiner M, Singh S,. Short out-patient pulmonary rehabilitation programme reduces readmission following a hospitalisation for an exacerbation of COPD. Respirology 2013; 18: 1063-1068.
33. Puhan M,. Pulmonary rehabilitation after an exacerbation of chronic obstructive pulmonary disease-evidence for the applicability of trial results to practice populations. Respirology 2013; 18: 1039-1040.
34. Pleguezuelos E, Pérez ME, Guirao L, Samitier B, Costea M, Ortega P, González MV, Del C, Amin V, Ovejero L, et al. Effects of whole body vibration training in patients with severe chronic obstructive pulmonary disease. Respirology 2013; 18: 1028-1034.
35. Collins PF, Elia M, Stratton RJ,. Nutritional support and functional capacity in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respirology 2013; 18: 616-629.
36. Gurgun A, Deniz S, Argin M, Karapolat H,. Effects of nutritional supplementation combined with conventional pulmonary rehabilitation in muscle-wasted chronic obstructive pulmonary disease: a prospective, randomized and controlled study. Respirology 2013; 18: 495-500.
37. Johnston K, Young M, Grimmer K, Antic R, Frith P,. Frequency of referral to and attendance at a pulmonary rehabilitation program amongst patients admitted to a tertiary hospital with chronic obstructive pulmonary disease. Respirology 2013; 18: 1089-1094.
38. Monteagudo M, Rodriguez-Blanco T, Llagostera M, Valero C, Bayona X, Granollers S, Ferro JJ, Acedo M, Almeda J, Rodriguez-Latre L, et al. Effect of health professional education on outcomes of chronic obstructive pulmonary disease in primary care: a non randomized clinical trial. Respirology 2013; 18: 718-727.
39. Johnston CL, Maxwell LJ, Boyle E, Maguire GP, Alison JA,. Improving chronic lung disease management in rural and remote Australia: the Breathe Easy Walk Easy programme. Respirology 2013; 18: 161-169.
40. Thompson PJ, Salvi S, Lin J, Cho YJ, Eng P, Abdul Manap R, Boonsawat W, Hsu J-Y, Faruqi RA, Moreno-Cantu JJ, et al. Insights, attitudes and perceptions about asthma and its treatment: findings from a multinational survey of patients from 8 Asia-Pacific countries and Hong Kong. Respirology 2013; 18: 957-967.
41. Wang D, Xiao W, Ma D, Zhang Y, Wang Q, Wang C, Ji X, He B, Wu X, Chen H, et al. Cross-sectional epidemiological survey of asthma in Jinan, China. Respirology 2013; 18: 313-322.
42. Grover C, Goel N, Chugh K, Gaur SN, Armour C, van Asperen PP, Moles RJ, Saini B,. Medication use in Indian children with asthma: the user's perspective. Respirology 2013; 18: 807-813.
43. Patel M, Perrin K, Pritchard A, Williams M, Wijesinghe M, Weatherall M, Beasley R,. Accuracy of patient self-report as a measure of inhaled asthma medication use. Respirology 2013; 18: 546-552.
44. Atienza T, Aquino T, Fernández M, Boonsawat W, Kawai M, Kudo T, Ekelund J, Ivanov S, Carlsson L-G,. Budesonide/formoterol maintenance and reliever therapy via Turbuhaler versus fixed-dose budesonide/formoterol plus terbutaline in patients with asthma: phase III study results. Respirology 2013; 18: 354-363.
45. Chen A-H, Zeng G-Q, Chen R-C, Zhan J-Y, Sun L-H, Huang S-K, Yang C-Z, Zhong N,. Effects of nebulized high-dose budesonide on moderate-to-severe acute exacerbation of asthma in children: a randomized double blind placebo controlled study. Respirology 2013; 18 (Suppl. 3): 47-52.
46. Martin M, Shaw D,. Effect of inhaled corticosteroids on the microbiology of the respiratory tract. Respirology 2013; 18: 201-202.
47. Zhang L, Prietsch SOM, Mendes AP, Von Groll A, Rocha GP, Carrion L, Da Silva PEA,. Inhaled corticosteroids increase the risk of oropharyngeal colonization by Streptococcus pneumoniae in children with asthma. Respirology 2013; 18: 272-277.
48. Lee C-H, Jang EJ, Hyun MK, Lee NR, Kim K, Yim J-J,. Risk of hospital admission or emergency room visit for pneumonia in patients using respiratory inhalers: a case-crossover study. Respirology 2013; 18: 1116-1127.
49. Bao W, Chen Q, Lin Y, Liu H, Zhao G, Chen Z, Zhou X,. Efficacy of procaterol combined with inhaled budesonide for treatment of cough-variant asthma. Respirology 2013; 18: 53-61.
50. James AL, Knuiman MW, Divitini ML, Hui J, Hunter ML, Mulrennan SA, Musk AW,. Risk factors for respiratory symptoms in adults-the Busselton Health Study. Respirology 2013; 18: 1256-1260.
51. Brooks CR, Gibson PG, Douwes J, Dalen CJV, Simpson JL,. Relationship between airway neutrophilia and ageing in asthmatics and non-asthmatics. Respirology 2013; 18: 857-865.
52. Fujisawa T, Yasui H, Akamatsu T, Hashimoto D, Enomoto N, Inui N, Nakamura Y, Maekawa M, Suda T, Chida K,. Alveolar nitric oxide concentration reflects peripheral airway obstruction in stable asthma. Respirology 2013; 18: 522-527.
53. Takami S, Mochizuki H, Muramatsu R, Hagiwara S, Arakawa H,. Relationship between bronchial hyperresponsiveness and lung function in children age 5 and 6 with and without asthma. Respirology 2013; 18: 682-687.
54. Woolnough K, Blakey J, Pargeter N, Mansur A,. Acid suppression does not reduce symptoms from vocal cord dysfunction, where gastro-laryngeal reflux is a known trigger. Respirology 2013; 18: 553-554.
55. Hojo M, Ohta K, Iikura M, Mizutani T, Hirashima J, Sugiyama H,. Clinical usefulness of a guideline-based screening tool for the diagnosis of allergic rhinitis in asthmatics: the Self Assessment of Allergic Rhinitis and Asthma questionnaire. Respirology 2013; 18: 1016-1021.
56. Wark PAB, Tooze M, Powell H, Parsons K,. Viral and bacterial infection in acute asthma and chronic obstructive pulmonary disease increases the risk of readmission. Respirology 2013; 18: 996-1002.
57. Dixon AE,. Breathing what we eat. Respirology 2013; 18: 391-392.
58. Berthon BS, Macdonald-Wicks LK, Gibson PG, Wood LG,. Investigation of the association between dietary intake, disease severity and airway inflammation in asthma. Respirology 2013; 18: 447-454.
59. Bui DS, Burgess JA, Matheson MC, Erbas B, Perret J, Morrison S, Giles GG, Hopper JL, Thomas PS, Markos J, et al. Ambient wood smoke, traffic pollution and adult asthma prevalence and severity. Respirology 2013; 18: 1101-1107.
60. Wjst M, Sargurupremraj M, Arnold M,. Genome-wide association studies in asthma: what they really told us about pathogenesis. Curr. Opin. Allergy Clin. Immunol. 2013; 13: 112-118.
61. Hinds DA, McMahon G, Kiefer AK, Do CB, Eriksson N, Evans DM, St Pourcain B, Ring SM, Mountain JL, Francke U, et al. A genome-wide association meta-analysis of self-reported allergy identifies shared and allergy-specific susceptibility loci. Nat. Genet. 2013; 45: 907-911.
62. Liang S, Wei X, Gong C, Wei J, Chen Z, Chen X, Wang Z, Deng J,. Significant association between asthma risk and the GSTM1 and GSTT1 deletion polymorphisms: an updated meta-analysis of case-control studies. Respirology 2013; 18: 774-783.
63. Roscioli E, Hamon R, Ruffin RE, Zalewski P, Grant J, Lester S,. X-linked inhibitor of apoptosis single nucleotide polymorphisms and copy number variation are not risk factors for asthma. Respirology 2013; 18: 697-703.
64. Goh F, Shaw JG, Savarimuthu Francis SM, Vaughan A, Morrison L, Relan V, Marshall HM, Dent AG, O'Hare PE, Hsiao A, et al. Personalizing and targeting therapy for COPD-the role of molecular and clinical biomarkers. Expert. Rev. Respir. Med. 2013; 7: 593-605.
65. Kim WJ, Oh Y-M, Lee JH, Park C-S, Park SW, Park JS, Lee SD,. Genetic variants in HHIP are associated with FEV1 in subjects with COPD. Respirology 2013; 18: 1202-1209.
66. Zhou JJ, Cho MH, Castaldi PJ, Hersh CP, Silverman EK, Laird NM,. Heritability of chronic obstructive pulmonary disease and related phenotypes in smokers. Am. J. Respir. Crit. Care Med. 2013; 188: 941-947.
67. Guan J, Liu X-S, Xu Y-J, Xu X-L, Yang Y-S, Wang R,. Relationship between the microsatellite D2S388-5 and D2S2232 polymorphisms and chronic obstructive pulmonary disease in the Chinese Kazakh population. Respirology 2013; 18: 303-307.
68. Johnson L, Shah I, Loh AX, Vinall LE, Teixeira AS, Rousseau K, Holloway JW, Hardy R, Swallow DM,. MUC5AC and inflammatory mediators associated with respiratory outcomes in the British 1946 birth cohort. Respirology 2013; 18: 1003-1010.
69. Martinez FD, Vercelli D,. Asthma. Lancet 2013; 382: 1360-1372.
70. Liang L, Li F, Bao A, Zhang M, Chung KF, Zhou X,. Activation of p38 MAPK in ovalbumin and ozone-induced mouse model of asthma. Respirology 2013; 18 (Suppl. 3): 20-29.
71. Takeda M, Tanabe M, Ito W, Ueki S, Konnno Y, Moritoki Y, Kayaba H, Chihara J,. Gender difference in allergic airway remodelling and immunoglobulin production in mouse model of asthma. Respirology 2013; 18: 797-806.
72. Porsbjerg CM, Gibson PG, Pretto JJ, Salome CM, Brown NJ, Berend N, King GG,. Relationship between airway pathophysiology and airway inflammation in older asthmatics. Respirology 2013; 18: 1128-1134.
73. Holgate ST,. Innate and adaptive immune responses in asthma. Nat. Med. 2012; 18: 673-683.
74. Holt PG, Sly PD,. Viral infections and atopy in asthma pathogenesis: new rationales for asthma prevention and treatment. Nat. Med. 2012; 18: 726-735.
75. Holtzman MJ,. Asthma as a chronic disease of the innate and adaptive immune systems responding to viruses and allergens. J. Clin. Invest. 2012; 122: 2741-2748.
76. Simpson JL, Gibson PG, Yang IA, Upham J, James A, Reynolds PN, Hodge S, AMAZES Study Research Group. Impaired macrophage phagocytosis in non-eosinophilic asthma. Clin. Exp. Allergy 2013; 43: 29-35.
77. Ichikawa T, Hayashi R, Suzuki K, Imanishi S, Kambara K, Okazawa S, Inomata M, Yamada T, Yamazaki Y, Koshimizu Y, et al. Sirtuin 1 activator SRT1720 suppresses inflammation in an ovalbumin-induced mouse model of asthma. Respirology 2013; 18: 332-339.
78. Francis SM, Tan ME, Fung PR, Shaw JG, Semmler AB, Nataatmadja M, Bowman RV, Fong KM, Yang IA,. Peripheral compartment innate immune response to Haemophilus influenzae and Streptococcus pneumoniae in chronic obstructive pulmonary disease patients. Innate. Immun. 2013; 19: 428-437.
79. Kim W-D, Chi H-S, Choe K-H, Oh Y-M, Lee S-D, Kim K-R, Yoo K-H, Ngan DA, Elliott WM, Granville DJ, et al. A possible role for CD8+ and non-CD8+ cell granzyme B in early small airway wall remodelling in centrilobular emphysema. Respirology 2013; 18: 688-696.
80. Hodge G, Mukaro V, Holmes M, Reynolds PN, Hodge S,. Enhanced cytotoxic function of natural killer and natural killer T-like cells associated with decreased CD94 (Kp43) in the chronic obstructive pulmonary disease airway. Respirology 2013; 18: 369-376.
81. Albacker LA, Chaudhary V, Chang YJ, Kim HY, Chuang YT, Pichavant M, DeKruyff RH, Savage PB, Umetsu DT,. Invariant natural killer T cells recognize a fungal glycosphingolipid that can induce airway hyperreactivity. Nat. Med. 2013; 19: 1297-1304.
82. Barnig C, Cernadas M, Dutile S, Liu X, Perrella MA, Kazani S, Wechsler ME, Israel E, Levy BD,. Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma. Sci. Transl. Med. 2013; 5: 174ra26.
83. Yin Y, Hou G, Li E, Wang Q, Kang J,. Regulation of cigarette smoke-induced toll-like receptor 4 expression by peroxisome proliferator- activated receptor-gamma agonists in bronchial epithelial cells. Respirology 2013; 18 (Suppl. 3): 30-39.
84. Roca-Ferrer J, Pérez-Gonzalez M, Garcia-Garcia FJ, Pereda J, Pujols L, Pujols L, Alobid I, Mullol J, Picado C,. Low prostaglandin E2 and cyclooxygenase expression in nasal mucosa fibroblasts of aspirin-intolerant asthmatics. Respirology 2013; 18: 711-717.
85. Vanders RL, Gibson PG, Wark PAB, Murphy VE,. Alterations in inflammatory, antiviral and regulatory cytokine responses in peripheral blood mononuclear cells from pregnant women with asthma. Respirology 2013; 18: 827-833.
86. Haghi M, Traini D, Postma DS, Bebawy M, Young PM,. Mediated fluticasone uptake across Calu-3 cells by salmeterol as combination powder inhaler. Respirology 2013; 18: 1197-1201.
87. Heijink IH, Berge MVD,. Are salmeterol's beneficial effects on corticosteroid action in the airways executed at the epithelial barrier? Respirology 2013; 18: 1165-1166.
88. Rüdiger JJ, Gencay M, Yang JQ, Bihl M, Tamm M, Roth M,. Fast beneficial systemic anti-inflammatory effects of inhaled budesonide and formoterol on circulating lymphocytes in asthma. Respirology 2013; 18: 840-847.
89. Dai S, Yin K, Yao X, Zhou L,. Inhibition of interleukin-13 gene expression by triptolide in activated T lymphocytes. Respirology 2013; 18: 1249-1255.
90. Sinclair K, Yerkovich ST, Chambers DC,. Mesenchymal stem cells and the lung. Respirology 2013; 18: 397-411.
91. Ghaedi M, Calle EA, Mendez JJ, Gard AL, Balestrini J, Booth A, Bove PF, Gui L, White ES, Niklason LE,. Human iPS cell-derived alveolar epithelium repopulates lung extracellular matrix. J. Clin. Invest. 2013; 123: 4950-4962.
92. Wagner DE, Bonvillain RW, Jensen T, Girard ED, Bunnell BA, Finck CM, Hoffman AM, Weiss DJ,. Can stem cells be used to generate new lungs? Ex vivo lung bioengineering with decellularized whole lung scaffolds. Respirology 2013; 18: 895-911.
93. Bertoncello I, McQualter JL,. Lung stem cells: do they exist? Respirology 2013; 18: 587-595.
94. Mora AL, Rojas M,. Adult stem cells for chronic lung diseases. Respirology 2013; 18: 1041-1046.